[1] Shen T, Liu Y, Shang J, at al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology, 2019, 156: 2230-2241. [2] Padda MS, Sanchez M, Akhtar AJ, at al. Drug-induced cholestasis. Hepatology, 2011, 53: 1377-1387. [3] 厉文,袁芳,王来友.药物性胆汁淤积发生机制与防治研究进展.世界华人消化杂志,2019,27:1295-1303. [4] 于乐成,茅益民,陈成伟.药物性肝损伤诊治指南.肝脏,2015,20:750-767. [5] European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009, 51: 237-267. [6] 胆汁淤积性肝病诊断和治疗共识(2015).肝脏,2015,20:950-959. [7] 魏小丰,韩子岩.血清碱性磷酸酶与γ-谷氨酰转肽酶水平及其倍值比对胆汁淤积性肝病的鉴别价值.中华诊断学电子杂志,2017,5:115-119. [8] 原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015).肝脏,2015,20:960-968. [9] Kleiner DE. Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am, 2017, 46: 273-296. [10] Reshetnyak VI. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World J Gastroenterol, 2015, 21: 7683-7708. [11] 申弘,胡萌,魏泽辉,等.胆汁的生成、分泌、排泄及胆汁淤积发生机制.临床肝胆病杂志,2019,35:431-437. [12] 洪佳,吴晓宁,尤红.胆汁淤积性肝病的规范化诊断.实用肝脏病杂志,2019,22:758-760. [13] 陈伟,杨沛,段雷波.5'-核苷酸酶的测定及临床意义.中华检验医学杂志,2004,27:154-155. [14] Sapey T, Mendler MH, Guyader D, et al. Respective value of alkaline phosphatase, gamma-glutamyl transpeptidase and 5' nucleotidase serum activity in the diagnosis of cholestasis: a prospective study of 80 patients. J Clin Gastroenterol, 2000, 30: 259-263. [15] Hyder MA, Hasan M, Mohieldein A, et al. Comparative Study of 5'-Nucleotidase Test in Various Liver Diseases. J Clin Diagn Res, 2016, 10: BC01-03. [16] Sotil EU, Jensen DM. Serum enzymes associated with cholestasis. Clin Liver Dis, 2004, 8: 41-54. |